---
title: "ICS OPPORTUNITIES II LLC — Ownership Dossier"
canonical: https://whiteintel.dev/entity/c477cea4-e508-57f7-abfa-0c85455f07b6
json: https://whiteintel.dev/api/public/dossier/c477cea4-e508-57f7-abfa-0c85455f07b6
identifier: sec:0001783647
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ICS OPPORTUNITIES II LLC

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001783647`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/c477cea4-e508-57f7-abfa-0c85455f07b6  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/c477cea4-e508-57f7-abfa-0c85455f07b6  

## Ownership & control

### Holdings / subsidiaries

- **Sensei Biotherapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/11dde184-64f2-5b88-ba68-488c525b5320

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ICS OPPORTUNITIES II LLC**. Human view: https://whiteintel.dev/entity/c477cea4-e508-57f7-abfa-0c85455f07b6 · Structured JSON: https://whiteintel.dev/api/public/dossier/c477cea4-e508-57f7-abfa-0c85455f07b6._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._